Literature DB >> 24425802

Osteoblastic niche supports the growth of quiescent multiple myeloma cells.

Zheng Chen1, Robert Z Orlowski, Michael Wang, Larry Kwak, Nami McCarty.   

Abstract

The heterogeneity of multiple myeloma (MM) contributes to variable responses to therapy. In this study, we aim to correlate the heterogeneity of MM to the presence of quiescent cells using the PKH26 dye. We tracked the rare quiescent cells in different niches of the bone marrow by allowing the cells to cycle in vivo. Surprisingly, quiescent PKH(+) MM cells prefer to reside within the osteoblastic niches of the bone marrow (PKH(+)/OS) rather than the vascular (VS) niches or the spleen. These cells (PKH(+)/OS) displayed enhanced stemlike properties by forming colonies in semisolid medium. PKH(+) cells were highly tumorigenic compared with PKH(-) cells and were resistant to a variety of drugs. However, the levels of drug resistance were somewhat similar regardless of where the PKH(+) cells were isolated. Our data indicate that osteoblastic niches support the growth of quiescent PKH(+) cells and allow them to have stemlike functions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24425802      PMCID: PMC3975258          DOI: 10.1182/blood-2013-07-517136

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Hematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cells.

Authors:  S M Lanzkron; M I Collector; S J Sharkis
Journal:  Blood       Date:  1999-03-15       Impact factor: 22.113

2.  Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis.

Authors:  C M Traycoff; S T Kosak; S Grigsby; E F Srour
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

3.  Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma.

Authors:  Hyun Joo Jung; Zheng Chen; Luis Fayad; Michael Wang; Jorge Romaguera; Larry W Kwak; Nami McCarty
Journal:  Exp Hematol       Date:  2011-10-21       Impact factor: 3.084

4.  Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma.

Authors:  Hyun Joo Jung; Zheng Chen; Nami McCarty
Journal:  Leuk Lymphoma       Date:  2011-06

Review 5.  Stem cell quiescence.

Authors:  Ling Li; Ravi Bhatia
Journal:  Clin Cancer Res       Date:  2011-05-18       Impact factor: 12.531

6.  Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules.

Authors:  S Huang; P Law; K Francis; B O Palsson; A D Ho
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

7.  Characterization of clonogenic multiple myeloma cells.

Authors:  William Matsui; Carol Ann Huff; Qiuju Wang; Matthew T Malehorn; James Barber; Yvette Tanhehco; B Douglas Smith; Curt I Civin; Richard J Jones
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

8.  Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?

Authors:  J E Noll; S A Williams; L E Purton; A C W Zannettino
Journal:  Blood Cancer J       Date:  2012-09-14       Impact factor: 11.037

  8 in total
  33 in total

1.  ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.

Authors:  Zheng Chen; Albert E Teo; Nami McCarty
Journal:  Clin Cancer Res       Date:  2015-09-08       Impact factor: 12.531

Review 2.  Dynamic interplay between bone and multiple myeloma: emerging roles of the osteoblast.

Authors:  Michaela R Reagan; Lucy Liaw; Clifford J Rosen; Irene M Ghobrial
Journal:  Bone       Date:  2015-02-26       Impact factor: 4.398

Review 3.  Retinoic acid, CYP26, and drug resistance in the stem cell niche.

Authors:  Salvador Alonso; Richard J Jones; Gabriel Ghiaur
Journal:  Exp Hematol       Date:  2017-07-25       Impact factor: 3.084

4.  Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.

Authors:  J Huang; P Woods; D Normolle; J P Goff; P V Benos; C J Stehle; R A Steinman
Journal:  Breast Cancer Res Treat       Date:  2016-11-16       Impact factor: 4.872

Review 5.  Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.

Authors:  G Shay; L Hazlehurst; C C Lynch
Journal:  J Mol Med (Berl)       Date:  2015-10-01       Impact factor: 4.599

6.  Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance.

Authors:  Salvador Alonso; Daniela Hernandez; Yu-Ting Chang; Christian B Gocke; Megan McCray; Ravi Varadhan; William H Matsui; Richard J Jones; Gabriel Ghiaur
Journal:  J Clin Invest       Date:  2016-10-24       Impact factor: 14.808

7.  HIF-1α and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress.

Authors:  Clémence Coudre; Julien Alani; William Ritchie; Véronique Marsaud; Brigitte Sola; Julie Cahu
Journal:  Cell Cycle       Date:  2016-06-24       Impact factor: 4.534

Review 8.  Adipose, Bone, and Myeloma: Contributions from the Microenvironment.

Authors:  Michelle M McDonald; Heather Fairfield; Carolyne Falank; Michaela R Reagan
Journal:  Calcif Tissue Int       Date:  2016-06-24       Impact factor: 4.333

9.  Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation.

Authors:  Efraín A Cermeño; Andrés J García
Journal:  Curr Stem Cell Rep       Date:  2016-02-09

Review 10.  Bone metastasis: the importance of the neighbourhood.

Authors:  Peter I Croucher; Michelle M McDonald; T John Martin
Journal:  Nat Rev Cancer       Date:  2016-05-25       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.